Profile data is unavailable for this security.
About the company
Sinocelltech Group Ltd is a China-based company mainly engaged in the research, development and industrialization of biopharmaceutical products. The Company focuses on monoclonal antibodies, recombinant proteins and vaccine products. Its main products are SCT800, SCT200, SCT-I10A, SCT400, SCT510, SCT1000 and SCT630, among others. The Company is also engaged in asset leasing business and payment collection business.
- Revenue in CNY (TTM)2.45bn
- Net income in CNY-24.64m
- Incorporated2007
- Employees2.33k
- LocationSinocelltech Group LtdBlock 5, No. 31 Kechuang Qi StreetBeijing Economic and Technological DevelBEIJING 100176ChinaCHN
- Phone+86 1 058628328
- Fax+86 1 058628299
- Websitehttps://www.sinobiological.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Thera Solutions Ltd | 825.18m | -377.67m | 9.12bn | 1.17k | -- | 10.77 | -- | 11.05 | -0.9121 | -0.9121 | 1.99 | 2.05 | 0.3533 | 1.00 | 6.83 | 707,092.40 | -16.17 | -23.62 | -26.76 | -30.81 | 69.81 | 79.76 | -45.77 | -106.72 | 0.716 | -27.47 | 0.4531 | -- | 54.86 | -- | 17.87 | -- | -3.78 | -- |
| Mabwell Shanghai Bioscience Co Ltd | 169.42m | -1.07bn | 9.54bn | 1.40k | -- | 4.98 | -- | 56.32 | -2.69 | -2.69 | 0.424 | 4.80 | 0.0379 | 0.089 | 9.74 | 113,628.50 | -24.10 | -37.61 | -30.74 | -45.95 | 90.50 | 81.54 | -636.41 | -2,112.26 | 1.25 | -41.98 | 0.5339 | -- | 361.03 | 27.88 | -10.28 | -- | 17.35 | -- |
| InnoCare Pharma Ltd | 898.92m | -375.51m | 12.73bn | 1.09k | -- | 3.55 | -- | 14.16 | -0.2325 | -0.2325 | 0.537 | 3.86 | 0.0922 | 1.32 | 3.73 | 825,457.90 | -4.02 | -- | -4.78 | -- | 84.50 | -- | -43.57 | -- | 7.65 | -- | 0.1547 | -- | 18.09 | -- | 28.80 | -- | -- | -- |
| Joinn Laboratories China Co Ltd | 2.12bn | -912.86k | 12.97bn | 2.59k | -- | 1.76 | -- | 6.10 | -0.0064 | -0.0064 | 2.82 | 10.68 | 0.2151 | 0.7714 | 7.32 | -- | -0.09 | 8.99 | -0.106 | 11.07 | 31.83 | 46.76 | -0.4184 | 32.01 | 2.85 | 1.25 | 0.0089 | 23.81 | 4.78 | 42.20 | -63.04 | 29.66 | 8.21 | 23.46 |
| RemeGen Co Ltd | 1.52bn | -1.55bn | 16.25bn | 3.62k | -- | 8.46 | -- | 10.67 | -2.88 | -2.88 | 2.83 | 4.35 | 0.2712 | 0.4446 | 5.00 | 421,122.40 | -27.65 | -18.66 | -36.21 | -23.69 | 78.65 | 81.64 | -101.95 | -102.21 | 0.9558 | -32.19 | 0.5167 | -- | 40.26 | 141.16 | -51.30 | -- | 59.07 | -- |
| Sinocelltech Group Ltd | 2.45bn | -24.64m | 17.73bn | 2.33k | -- | -- | -- | 7.25 | -0.0553 | -0.0553 | 5.49 | -0.2874 | 0.8146 | 0.4624 | 5.26 | 1,048,041.00 | -0.8674 | -40.17 | -2.70 | -74.63 | 95.83 | 95.42 | -1.06 | -108.20 | 0.588 | 5.45 | 1.05 | -- | 84.46 | 264.19 | 23.70 | -- | 37.54 | -- |
| Dizal Pharmaceutical Co Ltd | 389.64m | -837.22m | 19.91bn | 581.00 | -- | 46.48 | -- | 51.11 | -2.04 | -2.04 | 0.9471 | 1.03 | 0.235 | 0.4033 | 6.15 | 670,632.10 | -56.00 | -46.02 | -83.89 | -52.99 | 97.17 | 57.53 | -238.28 | -2,081.54 | 1.66 | -193.39 | 0.674 | -- | -- | 18.29 | -50.50 | -- | 21.35 | -- |
| Shanghai Allist Pharmaceuticals Co Ltd | 3.20bn | 1.30bn | 25.22bn | 1.04k | 19.45 | 5.19 | -- | 7.87 | 2.88 | 2.88 | 7.12 | 10.81 | 0.6811 | 3.60 | 11.38 | 3,068,832.00 | 27.57 | 0.6405 | 30.38 | 0.6933 | 94.43 | 96.42 | 40.47 | 2.54 | 6.89 | -- | 0.0003 | 211.88 | 155.14 | 237.34 | 393.54 | -- | 13.53 | -- |
Data as of Nov 22 2024. Currency figures normalised to Sinocelltech Group Ltd's reporting currency: Chinese Yuan Renminbi CNY
2.84%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2024 | 2.32m | 0.52% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 1.68m | 0.38% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2024 | 1.54m | 0.35% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 1.26m | 0.28% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 1.19m | 0.27% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2024 | 1.12m | 0.25% |
| Chang Xin Asset Management Co., Ltd.as of 30 Jun 2024 | 901.06k | 0.20% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 898.60k | 0.20% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 848.30k | 0.19% |
| Tian Hong Asset Management Co., Ltd.as of 30 Jun 2024 | 815.36k | 0.18% |
More ▼
Data from 30 Jun 2024 - 11 Nov 2024Source: FactSet Research Systems Inc.
